Clinical trial / 2018
Caffeine improves cycling endurance only in athletes with the CYP1A2 AA genotype.
In a randomized, double-blind trial, 101 male athletes completed a 10-km cycling time trial with 0, 2, or 4 mg/kg of caffeine. Overall, 4 mg/kg decreased cycling duration by 3% versus placebo (P = 0.01), but a significant caffeine-gene interaction occurred (P < 0.0001). Cycling time decreased at 2 mg/kg (-4.8%) and 4 mg/kg (-6.8%) in AA genotypes, showed no change in AC genotypes, and lengthened by 13.7% at 4 mg/kg in CC genotypes.
- Study type
- Randomized controlled crossover trial
- Who was studied
- 101 competitive male athletes (mean age 25 years)
- What was measured
- 10-km cycling time trial duration
THE PAPER
Caffeine, CYP1A2 Genotype, and Endurance Performance in Athletes.
Guest N, Corey P, Vescovi J, El-Sohemy A. Med Sci Sports Exerc, 2018.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.